| Financial Year |
March 31 2023 |
| Monetary Funds |
4,857,006,032.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
160,000.00 |
| Accounts Receivable |
821,414,290.11 |
| Advances to Suppliers |
26,025,331.49 |
| Other Receivables |
50,159,032.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
37,029,324.33 |
| Dividend Receivable |
-- |
| Inventories |
584,757,851.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,289,114.79 |
| Total Current Assets |
6,371,811,652.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
346,826,008.05 |
| Fixed Assetes |
967,087,528.59 |
| Under-construction Projects |
5,131,047,196.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
551,584,562.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,339,835.78 |
| Other Non-Current Assets |
936,289,452.57 |
| Sub-Total of Non-Current Assets |
8,575,746,998.99 |
| Total Assets |
14,947,558,651.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
659,977,859.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
98,463,261.44 |
| Taxes Payable |
55,742,627.50 |
| Interest Payable |
-- |
| Dividend Payable |
313,725.00 |
| Other payables |
47,200,086.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,694,622.25 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
863,078,457.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
479,620,843.31 |
| Deferred Income Tax Liabilities |
1,981,319,087.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,550,093,950.55 |
| Total Liabilities |
3,413,172,407.57 |
| Paid-In Capital(Or Share Stock) |
652,728,961.00 |
| Capital Surplus |
4,748,217,996.74 |
| Surplus Reserve |
94,373,873.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,779,559,210.40 |
| Minority Stockholder's Interest |
2,898,398,032.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,635,988,211.34 |
| Owner's Equity（Stockholder's Equity） |
11,534,386,244.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,947,558,651.60 |
